3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Waldenstrom Macroglobulinemia
1
Solitary Fibrous Tumor, Pleural
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Glioma
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Chondrosarcoma, Mesenchymal
1
Chondrosarcoma, Clear Cell
1
Chondrosarcoma
1
Cancer Pain
1
Breast Neoplasms
1
Anemia
1
Anatomic Stage III Breast Cancer AJCC v8
1
Adult Patients Who Are Receiving Oncologic Care
1
Adjustment Disorders
1
Interventions
Mitomycin
2
tislelizumab
1
molgramostim
1
cryoprecipitate coagulum
1
Tacrolimus
1
Standard of Care
1
Specimen Handling
1
Sirolimus
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Hyperthermic Intraperitoneal Chemotherapy
1
Fluorouracil
1
CTLA-4 Antigen
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pseudomyxoma Peritonei
×
Pharmacogenomic Testing
×
1 year
×
Clear all
No trials found.